Article
Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
Mayo Clinic proceedings - 1 Jul 2020
Mangaonkar Abhishek A, Patnaik Mrinal M
Abstract excerpt
With the advent of precision genomics, hereditary predisposition to hematopoietic neoplasms- collectively known as hereditary predisposition syndromes (HPS)-are being increasingly recognized in clinical practice. Familial clustering was first observed in patients with leukemia, which led to the identification of several germline variants, such as RUNX1, CEBPA, GATA2, ANKRD26, DDX41, and ETV6, among others, now...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
